pentobarbital will decrease the extent or influence of lumefantrine by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Coadministration with robust CYP3A4 inducers can lead to decreased serum concentrations and loss of antimalarial efficacyPentobarbital may cause Unwanted side effects that could impair your contemplating or … Read More